Your browser doesn't support javascript.
loading
Incidence of erythropoietin antibody-mediated pure red cell aplasia: the Prospective Immunogenicity Surveillance Registry (PRIMS).
Macdougall, Iain C; Casadevall, Nicole; Locatelli, Francesco; Combe, Christian; London, Gerard M; Di Paolo, Salvatore; Kribben, Andreas; Fliser, Danilo; Messner, Hans; McNeil, John; Stevens, Paul; Santoro, Antonio; De Francisco, Angel L M; Percheson, Paul; Potamianou, Anna; Foucher, Arnaud; Fife, Daniel; Mérit, Véronique; Vercammen, Els.
Afiliação
  • Macdougall IC; Department of Renal Medicine, King's College Hospital, London, UK.
  • Casadevall N; Service d'Immunologie et Hématologie Biologiques, Hôpital Saint Antoine, Paris, France.
  • Locatelli F; Division of Nephrology and Dialysis, Alessandro Manzoni Hospital, Lecco, Italy.
  • Combe C; Service de Néphrologie, Centre Hospitalier Universitaire de Bordeaux and Unité INSERM 1026, Université de Bordeaux, Bordeaux, France.
  • London GM; Centre de Recherche des Cordelliers, Ecole de Médecine, Paris, France.
  • Di Paolo S; Division of Nephrology and Dialysis, Hospital 'Dimiccoli', Barletta, Italy.
  • Kribben A; Klinik für Nephrologie, Universitätsklinik Essen, Essen, Germany.
  • Fliser D; Department Internal Medicine IV, Universitätsklinik Homburg/Saar, Homburg/Saar, Germany.
  • Messner H; Department of Medical Biophysics, University of Toronto, Toronto, Canada.
  • McNeil J; Department of Epidemiology and Preventive Medicine, Monash University Melbourne, Melbourne, Australia.
  • Stevens P; Department of Renal Medicine, Kent and Canterbury Hospital, Canterbury, UK.
  • Santoro A; Dialysis and Hypertension Department, Azienda Ospedaliero-Universitaria di Bologna, Policlinico S Orsola-Malpighi, Bologna, Italy.
  • De Francisco AL; Nephrology Department, Hospital Universitario Valdecilla, Santander, Spain.
  • Percheson P; Janssen, Pharmaceutical Companies of Johnson & Johnson, Titusville, NJ, USA.
  • Potamianou A; Janssen, Pharmaceutical Companies of Johnson & Johnson, Titusville, NJ, USA.
  • Foucher A; Janssen, Pharmaceutical Companies of Johnson & Johnson, Titusville, NJ, USA.
  • Fife D; Janssen, Pharmaceutical Companies of Johnson & Johnson, Titusville, NJ, USA.
  • Mérit V; Janssen, Pharmaceutical Companies of Johnson & Johnson, Titusville, NJ, USA.
  • Vercammen E; Janssen, Pharmaceutical Companies of Johnson & Johnson, Titusville, NJ, USA.
Nephrol Dial Transplant ; 30(3): 451-60, 2015 Mar.
Article em En | MEDLINE | ID: mdl-25239637
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Autoanticorpos / Eritropoetina / Aplasia Pura de Série Vermelha Tipo de estudo: Clinical_trials / Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies / Screening_studies Limite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: Nephrol Dial Transplant Assunto da revista: NEFROLOGIA / TRANSPLANTE Ano de publicação: 2015 Tipo de documento: Article País de afiliação: Reino Unido
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Autoanticorpos / Eritropoetina / Aplasia Pura de Série Vermelha Tipo de estudo: Clinical_trials / Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies / Screening_studies Limite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: Nephrol Dial Transplant Assunto da revista: NEFROLOGIA / TRANSPLANTE Ano de publicação: 2015 Tipo de documento: Article País de afiliação: Reino Unido